UniProt ID | RN114_HUMAN | |
---|---|---|
UniProt AC | Q9Y508 | |
Protein Name | E3 ubiquitin-protein ligase RNF114 | |
Gene Name | RNF114 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 228 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | E3 ubiquitin-protein ligase promoting the ubiquitination and degradation of the CDK inhibitor CDKN1A and probably also CDKN1B and CDKN1C. These activities stimulate cell cycle's G1-to-S phase transition and suppress cellular senescence. May play a role in spermatogenesis.. | |
Protein Sequence | MAAQQRDCGGAAQLAGPAAEADPLGRFTCPVCLEVYEKPVQVPCGHVFCSACLQECLKPKKPVCGVCRSALAPGVRAVELERQIESTETSCHGCRKNFFLSKIRSHVATCSKYQNYIMEGVKATIKDASLQPRNVPNRYTFPCPYCPEKNFDQEGLVEHCKLFHSTDTKSVVCPICASMPWGDPNYRSANFREHIQRRHRFSYDTFVDYDVDEEDMMNQVLQRSIIDQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
38 | Acetylation | VCLEVYEKPVQVPCG CHHEECCCCCCCCCC | 32.57 | 26051181 | |
38 | Ubiquitination | VCLEVYEKPVQVPCG CHHEECCCCCCCCCC | 32.57 | 22505724 | |
58 | Ubiquitination | ACLQECLKPKKPVCG HHHHHHHCCCCCCCH | 67.46 | - | |
60 | Ubiquitination | LQECLKPKKPVCGVC HHHHHCCCCCCCHHH | 69.03 | 29967540 | |
61 | Ubiquitination | QECLKPKKPVCGVCR HHHHCCCCCCCHHHH | 51.73 | 27667366 | |
96 | Ubiquitination | TSCHGCRKNFFLSKI CCCCHHHHHHHHHHH | 63.28 | 23000965 | |
96 (in isoform 2) | Ubiquitination | - | 63.28 | 21890473 | |
96 (in isoform 1) | Ubiquitination | - | 63.28 | 21890473 | |
96 | Malonylation | TSCHGCRKNFFLSKI CCCCHHHHHHHHHHH | 63.28 | 26320211 | |
102 | Acetylation | RKNFFLSKIRSHVAT HHHHHHHHHHHHHHH | 44.26 | 19608861 | |
102 (in isoform 1) | Ubiquitination | - | 44.26 | 21890473 | |
102 (in isoform 2) | Ubiquitination | - | 44.26 | 21890473 | |
102 | Sumoylation | RKNFFLSKIRSHVAT HHHHHHHHHHHHHHH | 44.26 | 19608861 | |
102 | Sumoylation | RKNFFLSKIRSHVAT HHHHHHHHHHHHHHH | 44.26 | - | |
102 | Ubiquitination | RKNFFLSKIRSHVAT HHHHHHHHHHHHHHH | 44.26 | 23000965 | |
105 | Phosphorylation | FFLSKIRSHVATCSK HHHHHHHHHHHHHHH | 26.28 | 23312004 | |
109 | Phosphorylation | KIRSHVATCSKYQNY HHHHHHHHHHHHHHH | 19.07 | 28102081 | |
111 | Phosphorylation | RSHVATCSKYQNYIM HHHHHHHHHHHHHHH | 30.00 | 28102081 | |
112 (in isoform 2) | Ubiquitination | - | 53.66 | 21890473 | |
112 | Acetylation | SHVATCSKYQNYIME HHHHHHHHHHHHHHH | 53.66 | 19608861 | |
112 | Ubiquitination | SHVATCSKYQNYIME HHHHHHHHHHHHHHH | 53.66 | 21963094 | |
112 (in isoform 1) | Ubiquitination | - | 53.66 | 21890473 | |
113 | Phosphorylation | HVATCSKYQNYIMEG HHHHHHHHHHHHHHH | 5.91 | 21945579 | |
116 | Phosphorylation | TCSKYQNYIMEGVKA HHHHHHHHHHHHHHH | 6.01 | 21945579 | |
122 | Neddylation | NYIMEGVKATIKDAS HHHHHHHHHEEECCC | 51.15 | 32015554 | |
122 | Ubiquitination | NYIMEGVKATIKDAS HHHHHHHHHEEECCC | 51.15 | 23000965 | |
122 (in isoform 2) | Ubiquitination | - | 51.15 | 21890473 | |
122 (in isoform 1) | Ubiquitination | - | 51.15 | 21890473 | |
126 (in isoform 2) | Ubiquitination | - | 42.77 | 21890473 | |
126 | Acetylation | EGVKATIKDASLQPR HHHHHEEECCCCCCC | 42.77 | 26051181 | |
126 | Sumoylation | EGVKATIKDASLQPR HHHHHEEECCCCCCC | 42.77 | - | |
126 | Sumoylation | EGVKATIKDASLQPR HHHHHEEECCCCCCC | 42.77 | - | |
126 | Ubiquitination | EGVKATIKDASLQPR HHHHHEEECCCCCCC | 42.77 | 23000965 | |
126 (in isoform 1) | Ubiquitination | - | 42.77 | 21890473 | |
129 | Phosphorylation | KATIKDASLQPRNVP HHEEECCCCCCCCCC | 37.36 | 24719451 | |
139 | Phosphorylation | PRNVPNRYTFPCPYC CCCCCCCEECCCCCC | 21.26 | 27642862 | |
149 | Ubiquitination | PCPYCPEKNFDQEGL CCCCCCCCCCCCCCH | 48.32 | 29967540 | |
149 | Acetylation | PCPYCPEKNFDQEGL CCCCCCCCCCCCCCH | 48.32 | 25953088 | |
161 (in isoform 2) | Ubiquitination | - | 56.97 | 21890473 | |
161 (in isoform 1) | Ubiquitination | - | 56.97 | 21890473 | |
161 | Ubiquitination | EGLVEHCKLFHSTDT CCHHHHHHHCCCCCC | 56.97 | 23000965 | |
165 | Phosphorylation | EHCKLFHSTDTKSVV HHHHHCCCCCCCCEE | 22.20 | 25627689 | |
169 | Ubiquitination | LFHSTDTKSVVCPIC HCCCCCCCCEEEEHH | 44.02 | 22505724 | |
186 | Phosphorylation | MPWGDPNYRSANFRE CCCCCCCCCCHHHHH | 16.01 | 22817900 | |
188 | Phosphorylation | WGDPNYRSANFREHI CCCCCCCCHHHHHHH | 19.73 | 28555341 | |
202 | Phosphorylation | IQRRHRFSYDTFVDY HHHHHCCCCCCCCCC | 23.27 | 27251275 | |
203 | Phosphorylation | QRRHRFSYDTFVDYD HHHHCCCCCCCCCCC | 19.11 | 27642862 | |
205 | Phosphorylation | RHRFSYDTFVDYDVD HHCCCCCCCCCCCCC | 19.82 | 27642862 | |
209 | Phosphorylation | SYDTFVDYDVDEEDM CCCCCCCCCCCHHHH | 16.74 | 28796482 | |
224 | Phosphorylation | MNQVLQRSIIDQ--- HHHHHHHHHHCC--- | 15.78 | 26074081 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RN114_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RN114_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KAD5_HUMAN | AK5 | physical | 16169070 | |
HS90A_HUMAN | HSP90AA1 | physical | 21571784 | |
UBC_HUMAN | UBC | physical | 18364390 | |
XAF1_HUMAN | XAF1 | physical | 23645206 | |
RN114_HUMAN | RNF114 | physical | 23645206 | |
TRI52_HUMAN | TRIM52 | physical | 22493164 | |
RNF38_HUMAN | RNF38 | physical | 22493164 | |
TRI55_HUMAN | TRIM55 | physical | 22493164 | |
RSSA_HUMAN | RPSA | physical | 21988832 | |
TNAP3_HUMAN | TNFAIP3 | physical | 25165885 | |
XAF1_HUMAN | XAF1 | physical | 25313037 | |
RN114_HUMAN | RNF114 | physical | 21571784 | |
USO1_HUMAN | USO1 | physical | 26186194 | |
IDI2_HUMAN | IDI2 | physical | 26186194 | |
IDI2_HUMAN | IDI2 | physical | 28514442 | |
USO1_HUMAN | USO1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102 AND LYS-112, AND MASSSPECTROMETRY. |